Global Influenza Diagnostics Market 2019-2023

SKU ID :TNV-14439853 | Published Date: 08-Jul-2019 | No. of pages: 143
PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: SEGMENTATION BY END-USER PART 07: SEGMENTATION BY INDICATION PART 08: MARKET SEGMENTATION BY PRODUCT Market segmentation by product Comparison by product Point-of-care testing - Market size and forecast 2018-2023 Immunodiagnostics - Market size and forecast 2018-2023 Molecular diagnostics - Market size and forecast 2018-2023 Market opportunity by product PART 09: CUSTOMER LANDSCAPE PART 10: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 11: DRIVERS AND CHALLENGES Market drivers Market challenges PART 12: MARKET TRENDS Surge in number of genetic characterization studies on influenza virus Increasing approvals of influenza diagnostic products by regulatory authorities Rising adoption of rapid diagnostic products in physician office laboratories PART 13: VENDOR LANDSCAPE Overview Landscape disruption PART 14: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Abbott Laboratories bioMérieux SA Bio-Rad Laboratories Inc. Danaher Corp. Thermo Fisher Scientific Inc. PART 15: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors   Exhibit 01: Years in consideration Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market characteristics analysis Exhibit 06: Market segments Exhibit 07: Market definition - Inclusions and exclusions checklist Exhibit 08: Market size 2018 Exhibit 09: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 10: Global market: Year-over-year growth 2019-2023 (%) Exhibit 11: Five forces analysis 2018 Exhibit 12: Five forces analysis 2023 Exhibit 13: Bargaining power of buyers Exhibit 14: Bargaining power of suppliers Exhibit 15: Threat of new entrants Exhibit 16: Threat of substitutes Exhibit 17: Threat of rivalry Exhibit 18: Market condition - Five forces 2018 Exhibit 19: Influenza A diagnostic product in commercial market space: Exhibit 20: Product - Market share 2018-2023 (%) Exhibit 21: Comparison by product Exhibit 22: Point-of-care testing - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Point-of-care testing - Year-over-year growth 2019-2023 (%) Exhibit 24: Immunodiagnostics - Market size and forecast 2018-2023 ($ millions) Exhibit 25: Immunodiagnostics - Year-over-year growth 2019-2023 (%) Exhibit 26: Molecular diagnostics - Market size and forecast 2018-2023 ($ millions) Exhibit 27: Molecular diagnostics - Year-over-year growth 2019-2023 (%) Exhibit 28: Market opportunity by product Exhibit 29: Customer landscape Exhibit 30: Customer landscape analysis Exhibit 31: Market share by geography 2018-2023 (%) Exhibit 32: Geographic comparison Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 34: North America - Year-over-year growth 2019-2023 (%) Exhibit 35: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 36: Europe - Year-over-year growth 2019-2023 (%) Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 38: Asia - Year-over-year growth 2019-2023 (%) Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 40: ROW - Year-over-year growth 2019-2023 (%) Exhibit 41: Key leading countries Exhibit 42: Market opportunity Exhibit 43: Decision framework Exhibit 44: Impact of drivers and challenges Exhibit 45: Exhibit: Nucleic acid detection-based US FDA-cleared influenza diagnostics test in commercial market (as of 2019) Exhibit 46: Vendor landscape Exhibit 47: Landscape disruption Exhibit 48: Vendor landscape analysis Exhibit 49: Vendors covered Exhibit 50: Vendor classification Exhibit 51: Market positioning of vendors Exhibit 52: Abbott Laboratories - Vendor overview Exhibit 53: Abbott Laboratories - Business segments Exhibit 54: Abbott Laboratories - Organizational developments Exhibit 55: Abbott Laboratories - Geographic focus Exhibit 56: Abbott Laboratories - Segment focus Exhibit 57: Abbott Laboratories - Key offerings Exhibit 58: bioMérieux SA - Vendor overview Exhibit 59: bioMérieux SA - Business segments Exhibit 60: bioMérieux SA - Organizational developments Exhibit 61: bioMérieux SA - Geographic focus Exhibit 62: bioMérieux SA - Key offerings Exhibit 63: Bio-Rad Laboratories Inc. - Vendor overview Exhibit 64: Bio-Rad Laboratories Inc. - Business segments Exhibit 65: Bio-Rad Laboratories Inc. - Organizational developments Exhibit 66: Bio-Rad Laboratories Inc. - Geographic focus Exhibit 67: Bio-Rad Laboratories Inc. - Segment focus Exhibit 68: Bio-Rad Laboratories Inc. - Key offerings Exhibit 69: Danaher Corp. - Vendor overview Exhibit 70: Danaher Corp. - Business segments Exhibit 71: Danaher Corp. - Organizational developments Exhibit 72: Danaher Corp. - Geographic focus Exhibit 73: Danaher Corp. - Segment focus Exhibit 74: Danaher Corp. - Key offerings Exhibit 75: Thermo Fisher Scientific Inc. - Vendor overview Exhibit 76: Thermo Fisher Scientific Inc. - Business segments Exhibit 77: Thermo Fisher Scientific Inc. - Organizational developments Exhibit 78: Thermo Fisher Scientific Inc. - Geographic focus Exhibit 79: Thermo Fisher Scientific Inc. - Segment focus Exhibit 80: Thermo Fisher Scientific Inc. - Key offerings Exhibit 81: Validation techniques employed for market sizing Exhibit 82: List of abbreviations Exhibit 83: Definition of market positioning of vendors
Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., and Thermo Fisher Scientific Inc.
  • PRICE
  • $2500
    $4000
    Buy Now

Our Clients